Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2574951012 | Pioglitazone 15mg/metformin 850mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2578380016 | Pioglitazone 15mg/metformin 850mg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2694397012 | Metformin 850mg/pioglitazone 15mg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3470372017 | Product containing pioglitazone 15 mg and metformin 850 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3487102019 | Product containing pioglitazone 15 mg and metformin 850 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3502077013 | Pioglitazone 15 mg and metformin 850 mg oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3570298017 | Product containing only pioglitazone 15 mg and metformin 850 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3570299013 | Product containing only pioglitazone 15 mg and metformin 850 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682051019 | Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682052014 | Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682053016 | Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Metformin and pioglitazone only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Metformin hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Pioglitazone hydrochloride | true | Inferred relationship | Some | 2 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing metformin and pioglitazone (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Metformin (substance) | false | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Thiazolidinedione (substance) | false | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Pioglitazone (substance) | false | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Metformin hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Pioglitazone hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Metformin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Pioglitazone (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 15 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Metformin hydrochloride | false | Inferred relationship | Some | 2 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 850 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Metformin hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Metformin hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 850 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Pioglitazone hydrochloride | false | Inferred relationship | Some | 2 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Pioglitazone (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 15 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Metformin- and pioglitazone-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Pioglitazone hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | 2 | |
| Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR